“Cetuximab plus weekly oxaliplatin / 5FU / FA (FUFOX) in 1st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper GI study group”. - Lordick,F.; Lorenzen,S. (J Clin Oncol, ASCO Annual Meeting Proceedings Part I, 2007)